Dr. Paul Tauchner is a Munich-based Patent Attorney with Vossius & Partner Patentanwälte Rechtsanwälte mbB, practicing in the field of Intellectual Property Law. He studied chemistry at the University of Munich and received his Ph.D. from the Institute of Organic Chemistry in 1974. After completing his professional training in intellectual property at VOSSIUS & PARTNER, he was admitted as a German Patent Attorney (Patentanwalt) in 1977, a European Patent Attorney in 1978, and a European Trademark Attorney in 1994. He has been a partner of the firm since 1980.
Dr. Tauchner focuses his practice on patent opposition proceedings, patent litigation, and advising clients on freedom-to-operate and patent validity matters. His work in Intellectual Property Law includes involvement in significant patent disputes and proceedings before the European Patent Office and national courts, including matters relating to Captopril, Terfenadine (prodrug), and Torasemide, as well as the Taxol and Viagra opposition proceedings before the EPO and the Olanzapin validity defense.
In addition to his legal practice, Dr. Tauchner contributes to the development and discussion of patent law through writing and speaking engagements. He serves on the Editorial Board of „Patent World“ and has authored publications addressing patents in chemistry, the patentability of pharmaceutical substances, patent litigation, and invalidation proceedings. He regularly delivers lectures and seminars on European and German patent law in Japan, the United States, the United Kingdom, and Germany.